K. Sugiyama
- Surgery top 10%
- Molecular Biology
- Hepatology top 2%
- Epidemiology top 10%
- Oncology top 10%
- Co-authors
- Kunitada ShimotohnoNobuyuki KatoYutaka YonemuraToshitake TanakaSachio FushidaK KinoshitaItasu NinomiyaPolly Roy
- Topics
- Gastric Cancer Management and Outcomes (11 papers)SARS-CoV-2 and COVID-19 Research (6 papers)Hepatitis C virus research (6 papers)
- Partner nations
- JapanUnited StatesUnited Kingdom
In The Last Decade
K. Sugiyama
64 papers receiving 1.8k citations
Peers
Comparison fields: 5 of 114
- Surgery 497
- Molecular Biology 471
- Hepatology 437
- Epidemiology 413
- Oncology 264
Countries citing papers authored by K. Sugiyama
This map shows the geographic impact of K. Sugiyama's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K. Sugiyama with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K. Sugiyama more than expected).
Fields of papers citing papers by K. Sugiyama
This network shows the impact of papers produced by K. Sugiyama. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K. Sugiyama. The network helps show where K. Sugiyama may publish in the future.
Co-authorship network of co-authors of K. Sugiyama
This figure shows the co-authorship network connecting the top 25 collaborators of K. Sugiyama. A scholar is included among the top collaborators of K. Sugiyama based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with K. Sugiyama. K. Sugiyama is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 36 | |
| 3 | 5 | |
| 4 | Intraoperative chemohyperthermic peritoneal perfusion as an adjuvant to gastric cancer: final results of a randomized controlled study. | 165 |
| 5 | 105 | |
| 6 | 20 | |
| 7 | 4 | |
| 8 | 32 | |
| 9 | 49 | |
| 10 | [Correlation of DNA ploidy, c-erbB-2 protein tissue status, level of PCNA expression and clinical outcome in gastric carcinomas]. | 1 |
| 11 | [The study of continuous local arterial-infusion chemotherapy with 5-FU + CDDP for patients with severely advanced HCC--for the elongation of the life-span and the improvement of QOL]. | 4 |
| 12 | 1 | |
| 13 | 10 | |
| 14 | 68 | |
| 15 | 17 | |
| 16 | 48 | |
| 17 | [Multiple rectal carcinoids--with special reference to the histogenesis of these lesions]. | 4 |
| 18 | 1 | |
| 19 | Experimental Pseudomonas infection in mice: effect of single cyclophosphamide administration on Pseudomonas infection. | 3 |
| 20 | Experimental Pseudomonas infection in mice: acquired resistance against Pseudomonas septicemia and altered susceptibility in BCG infected mice. | 2 |
About K. Sugiyama
K. Sugiyama is a scholar working on Hepatology, Animal Science and Zoology and Infectious Diseases, having authored 64 papers that have together received 1.9k indexed citations. Recurring topics across this work include Gastric Cancer Management and Outcomes (11 papers), SARS-CoV-2 and COVID-19 Research (6 papers) and Hepatitis C virus research (6 papers). The work is most often cited by research in Hepatology (437 citations), Gastroenterology (106 citations) and Reproductive Medicine (126 citations). K. Sugiyama has collaborated with scholars based in Japan, United States and United Kingdom. Frequent co-authors include Kunitada Shimotohno, Nobuyuki Kato, Yutaka Yonemura, Toshitake Tanaka, Sachio Fushida, K Kinoshita, Itasu Ninomiya, Polly Roy, Yoshio Endou and J B Kahlon. Their work appears in journals such as Proceedings of the National Academy of Sciences, Cancer and Journal of Virology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.